It is attractive to speculate about the potential anti-autophagic mechanisms for the beneficial effects of neutralizing Annexin A2 in treating cancer, since this appears to have efficacy in a human breast tumour xenograft model, where an Annexin A2-neutralizing antibody reduced tumour growth51, 52. The gene discussed is ANXA2; the disease is neoplasm.